The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone.
about
Advances in Biomarkers for PCa Diagnostics and Prognostics-A Way towards Personalized Medicine.Neutrophil-lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysisPrognostic value of selected preoperative inflammation-based scores in patients with high-risk localized prostate cancer who underwent radical prostatectomy
P2860
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The Role of the Neutrophil to ...... ncer Treated with Abiraterone.
@en
type
label
The Role of the Neutrophil to ...... ncer Treated with Abiraterone.
@en
prefLabel
The Role of the Neutrophil to ...... ncer Treated with Abiraterone.
@en
P2093
P2860
P50
P356
P1476
The Role of the Neutrophil to ...... ncer Treated with Abiraterone.
@en
P2093
Andres Jan Schrader
Axel Semjonow
Julie Steinestel
Katrin Schlack
Martin Boegemann
P2860
P356
10.3390/IJMS18020380
P407
P577
2017-02-11T00:00:00Z